|
Monoclonal Antibodies Market in Colorectal Cancer to 2019 | Industry Shares …
PR Web (press release) GBI Research, has released the pharma report – “Monoclonal Antibodies Market in Colorectal Cancer to 2019 – Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth”. There are currently three monoclonal … Monoclonal Antibodies Market in Colorectal Cancer to 2019SBWire (press release) |
Straight from the heart: 'Gay for a Day' campaign goes viral – Times of India
|
Straight from the heart: ‘Gay for a Day’ campaign goes viral
Times of India MUMBAI: Celebrity hairstylist Sapna Bhavnani was ill at ease the whole of Wednesday after the SC judgement re-criminalising homosexuality. “As a woman in India today, you have to face so much injustice. This verdict was the last straw,” says Bhavnani … |
Jordanian, Saudi camels have MERS-CoV-like antibodies – CIDRAP
CIDRAPJordanian, Saudi camels have MERS-CoV-like antibodiesCIDRAPThe suspicion that Middle Eastern respiratory syndrome coronavirus (MERS-CoV) may be widespread in Middle Eastern camels grew today with reports that dromedary camels in Jordan and Saudi …
Canadian Cardiovascular Society Issues Guidelines to Improve Early Diagnosis … – 3BL Media (press release)
|
Canadian Cardiovascular Society Issues Guidelines to Improve Early Diagnosis …
3BL Media (press release) Philadelphia, PA, December 12, 2013 /3BL Media/ – Heart failure in children is an important cause of childhood health problems and death. The Children’s Heart Failure Study Group of the Canadian Cardiovascular Society, in collaboration with the … |
Idelalisib plus rituximab boosts survival in relapsed chronic lymphocytic leukemia – The Oncology Report
|
Idelalisib plus rituximab boosts survival in relapsed chronic lymphocytic leukemia
The Oncology Report NEW ORLEANS – Adding idelalisib to rituximab significantly extends survival in patients with heavily pretreated relapsed chronic lymphocytic leukemia unsuitable for chemotherapy, according to results from Study 116. The primary endpoint of median … |
Organ donor awareness program scheduled for December 14 at Marvell – Helena Daily World
|
Organ donor awareness program scheduled for December 14 at Marvell
Helena Daily World A tragic automobile accident cut short the life of 17-year-old Darnell Williams. Those who knew and loved the young man described him as having integrity and embracing a compassion for all people. When approached about organ donation, Darnell’s family … |
Ibrutinib and rituximab trigger 95 percent response rate among CLL patients – HealthCanal.com
Ibrutinib and rituximab trigger 95 percent response rate among CLL patientsHealthCanal.comNearly all of the high-risk chronic lymphocytic leukemia patients in a phase II clinical trial responded to treatment with the targeted therapy ibrutinib and the …
UMC transplant first: Man receives both pancreas and kidney – Jackson Clarion Ledger
|
UMC transplant first: Man receives both pancreas and kidney
Jackson Clarion Ledger Dr. Olivia Vaughan, second-year surgery resident at the University of Mississippi Medical Center, left, and Dr. Truman Earl, assistant professor of transplant surgery, prepare a donated pancreas on Dec. 5 for UMC’s first pancreas transplant. The … |
Tests in mice identify compound that may keep survivors of brain aneurysms … – The Almagest
|
Tests in mice identify compound that may keep survivors of brain aneurysms …
The Almagest This can lead to ischemic stroke, the most common type of stroke, caused by a blockage of a blood vessel in the brain. Death or serious disability may result. The Johns Hopkins researchers say S-4-CPG keeps glutamate “in check,” prevents or reduces … |
Monoclonal Antibodies Market in Colorectal Cancer to 2019 – Favorable Pricing … – SBWire (press release)
|
Monoclonal Antibodies Market in Colorectal Cancer to 2019 – Favorable Pricing …
SBWire (press release) The pharma report – “Monoclonal Antibodies Market in Colorectal Cancer to 2019 – Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth”. There are currently three monoclonal Antibody (mAb) treatments … |